Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Zhou XC, Qu JC. Moving beyond efficacy: Why, how and for whom exercise works in schizophrenia. World J Psychiatry 2026; 16(12): 120307 [DOI: 10.5498/wjp.120307]
World J Psychiatry. Dec 19, 2026; 16(12): 120307 Published online Dec 19, 2026. doi: 10.5498/wjp.120307
Moving beyond efficacy: Why, how and for whom exercise works in schizophrenia
Xin-Chu Zhou, Jia-Chen Qu
Xin-Chu Zhou, Institute of Physical Education, Wuchang Institute of Technology, Wuhan 430065, Hubei Province, China
Jia-Chen Qu, Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei Province, China
Author contributions: Zhou XC conceptualized the study and drafted the initial manuscript; Qu JC contributed to the mechanistic framework and precision medicine sections, and developed the analytical framework for dose-response and adherence. All authors critically reviewed and approved the final manuscript.
AI contribution statement: Grammarly and DeepL were used only for language polishing, grammar correction, and English expression refinement during manuscript preparation. The main text content was independently written by us, and no AI was used in study design. All figures and tables were created by ourselves.
Supported by 2025 Provincial Teaching Reform Research Project of Undergraduate Universities in Hubei Province, No. 2025513.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Jia-Chen Qu, PhD, Post Doctoral Researcher, Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, No. 169 East Lake Road, Wuchang District, Wuhan 430071, Hubei Province, China. qujc_doc@163.com
Received: February 24, 2026 Revised: March 31, 2026 Accepted: April 21, 2026 Published online: December 19, 2026 Processing time: 272 Days and 6.2 Hours
Abstract
Clinical rehabilitation in schizophrenia has long been limited by the treatment gap for negative symptoms and cognitive deficits. Although exercise interventions have proven universally effective, their translational trajectory continues to face challenges, including mechanistic fragmentation, lack of protocol standardization, and marked interindividual variability in response. This review aims to move beyond conventional “universal validation” and deconstruct the scientific logic underlying exercise interventions. First, at the “why” level, this review challenges the singular brain-derived neurotrophic factor-centric model and proposes an integrated, multi-system, multi-modal perspective wherein exercise acts synergistically through neuroplasticity, neurotransmitter homeostasis, systemic inflammation attenuation, and psychosocial behavioral activation. Second, at the “how” level, the review identifies an optimal dose window of moderate intensity, underscores the necessity of precise “type-to-symptom” matching, and highlights the core value of cognitive embedding and digital technologies in enhancing intervention efficacy and adherence. Third, at the “for whom” level, the review reveals the significant moderating effects of disease stage, genetic polymorphisms, and baseline inflammatory status, thereby advocating a stratified matching strategy based on individual biological and behavioral characteristics. Finally, a four-stage closed-loop precision prescription framework - “assessment-matching-implementation-monitoring” - is proposed to drive the paradigm shift toward “precision sports medicine” in exercise interventions, providing a scientific decision-making basis for long-term rehabilitation. Future researchers are supposed to focus on the integration of multi-modal biomarkers with artificial intelligence-driven digital technologies to propel exercise interventions from laboratory-based “universal validation” to clinical “precision application”, thereby maximizing individualized rehabilitation benefits.
Core Tip: Exercise interventions have demonstrated efficacy in alleviating symptoms of schizophrenia, but their mechanisms remain fragmented and clinical application inconsistent. This opinion review challenges the traditional brain-derived neurotrophic factor-centered model, proposing a multi-system, multi-modal perspective involving neuroplasticity, neurotransmitter homeostasis, systemic inflammation attenuation, and psychosocial behavioral activation. By addressing optimal dosage, exercise type-symptom matching, and individual response variability, we propose a precision exercise prescription framework that incorporates personalized strategies. Future researches are supposed to focus on the integration of multi-modal biomarkers and artificial intelligence to shift exercise from “universal validation” to clinical “precision application”, thereby maximizing individualized long-term rehabilitation outcomes in schizophrenia.